Aro Biotherapeutics
Aro Biotherapeutics is a biotechnology company based in Philadelphia, PA, that specializes in the development of tissue-targeted genetic medicines using their proprietary protein technology called Centyrins. They are focused on creating a new class of receptor-targeted genetic medicines by selectively modulating gene targets in disease tissues to achieve superior efficacy and safety.
With a product-focused platform, Aro Biotherapeutics is developing a pipeline of Centyrin-based therapeutic candidates and collaborating with industry partners to leverage Centyrins for tissue-specific targeting of therapeutics for a wide range of diseases. Their innovative approach involves discovering and optimizing receptor-specific Centyrins and conjugating them to oligonucleotides to precisely modulate gene targets in disease tissues.
Generated from the website
Also at this address
You might also like
Partial Data by Infogroup (c) 2025. All rights reserved.
